Spero Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	48.62	52.89	76.33	109.11	112.58	85.21
Short-Term Investments	-	-	-	-	33.82	41.7
Cash & Short-Term Investments	48.62	52.89	76.33	109.11	146.4	126.91
Cash Growth	-36.27%	-30.71%	-30.04%	-25.47%	15.36%	54.68%
Accounts Receivable	0.87	49.39	95.74	-	-	-
Other Receivables	1.59	3.09	1.55	1.08	2.64	6.18
Total Trade Receivables	2.46	52.48	97.29	1.08	2.64	6.18
Other Current Assets	1.25	1.91	4.18	3.38	8.83	6.06
Total Current Assets	52.32	107.28	131.21	113.57	157.87	139.15
Net Property, Plant & Equipment	1.69	3.11	4.16	5.49	7.56	8.78
Other Long-Term Assets	0.15	0.15	0.44	5.74	5.64	5.52
Total Assets	54.17	110.54	182.39	124.8	171.07	153.45
Accounts Payable	1.4	7.31	1.38	0.62	1.1	1.16
Accrued Expenses	7.81	17.72	6.56	8.97	14.35	12.24
Current Portion of Leases	1.9	1.75	1.72	1.69	1.36	0.95
Unearned Revenue	2.38	22.12	27.11	10.37	1.86	-
Other Current Liabilities	0.16	0.17	0.39	-	-	-
Total Current Liabilities	13.65	49.07	37.15	21.65	18.67	14.34
Long-Term Debt	-	-	-	-	48.41	-
Long-Term Leases	1.45	2.55	3.83	4.96	5.97	6.89
Other Long-Term Liabilities	12.58	12.8	34.52	22.26	9.73	0.18
Total Long-Term Liabilities	14.03	15.35	38.34	27.22	64.11	7.07
Total Liabilities	27.68	64.42	75.5	48.87	82.78	21.41
Preferred Stock	-	-	-	-	0	0
Common Stock	0.06	0.06	0.05	0.05	0.03	0.03
Additional Paid-in Capital	509.02	505.71	497.91	489.76	455.72	409.72
Accumulated Other Comprehensive Income	-	-	-	-	-0	-0.01
Retained Earnings	-482.59	-459.64	-391.07	-413.88	-367.46	-277.71
Shareholders' Equity	26.49	46.12	106.89	75.93	88.29	132.04
Total Liabilities & Equity	54.17	110.54	182.39	124.8	171.07	153.45
Total Debt	3.35	4.3	5.54	6.65	55.75	7.84
Net Cash (Debt)	45.27	48.59	70.79	102.46	90.65	119.07
Net Cash Growth	-6.85%	-31.36%	-30.91%	13.02%	-23.86%	55.64%
Net Cash Per Share	0.81	0.90	1.34	2.73	2.93	5.32
Book Value	26.49	46.12	106.89	75.93	88.29	132.04
Book Value Per Share	0.48	0.85	2.02	2.02	2.86	5.90
Tangible Book Value	26.49	46.12	106.89	75.93	88.29	132.04
Tangible Book Value Per Share	0.48	0.85	2.02	2.02	2.86	5.90

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q